In vitro study on efficacy of PHELA, an African traditional drug against SARS-CoV-2

In 2019, coronavirus has made the third apparition in the form of SARS-CoV-2, a novel strain of coronavirus that is extremely pathogenic and it uses the same receptor as SARS-CoV, the angiotensin-converting enzyme 2 (ACE2). However, more than 182 vaccine candidates have been announced; and 12 vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsabisa, M. G., Alexandre, K., Ibeji, Collins U., Tripathy, S., Erukainure, Ochuko L., Malatji, K., Chauke, S., Okole, B., Chabalala, H. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207029/
https://www.ncbi.nlm.nih.gov/pubmed/35718800
http://dx.doi.org/10.1038/s41598-022-13599-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207029/
https://www.ncbi.nlm.nih.gov/pubmed/35718800
http://dx.doi.org/10.1038/s41598-022-13599-y

Ejemplares similares